Endurant Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,211	Closed	-$446K	–	59
2022 Q3	$446K	Sell	9,211 -2,327	-20%	-$113K	0.15%	46
2022 Q2	$453K	Buy	+11,538	New	+$453K	0.16%	44